Climb Global Solutions, Inc. (CLMB) Market Cap & Valuation Ratios
Climb Global Solutions, Inc. (CLMB) has a market cap of $612.8M, a trailing P/E of 29.7 and a price-to-sales ratio of 0.9, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CLMBClimb Global Solutions, Inc.Follow CLMB — free
—
Price chart with a free account
- Market cap
- 612.8M
- P/E TTM
- 29.7
- Dividend yield
- 2.1%
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
Peers
electronics & computer distribution · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| CLMB | 0.6 | 29.7 | 0.8 | 15.5 | 6.7% | +23% | 4% | 28% |
| SNX | 20 | 15.1 | 0.3 | 9.9 | -4.1% | +24% | 3% | 12% |
| ARW | 11 | 13.4 | 0.4 | 9.3 | 7.7% | +26% | 3% | 11% |
| AVT | 7.2 | 21.9 | 0.4 | 12.8 | -4.9% | +24% | 3% | 7% |
| NSIT | 5.2 | 26.0 | 0.7 | 12.5 | 7.6% | +3% | 5% | 10% |
| CNXN | 2.2 | 23.5 | 0.6 | 14.8 | 1.5% | +3% | 4% | 11% |
| PLBL | 2.0 | — | 96.9 | — | -0.3% | -13% | -34% | — |
| SCSC | 1.2 | 16.8 | 0.4 | 10.2 | 9.3% | +6% | 3% | 8% |
| ITRN | 1.0 | 15.6 | 2.3 | 8.5 | 7.9% | +16% | 22% | 59% |
| Median of these 8 | 16.8 | 0.5 | 10.2 | 4.6% | +11% | 3% | 11% |
P/E 29.7 vs. a peer median of 16.8; EV/Sales 0.8 vs. 0.5. CLMB's own P/E sits at the 100th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesPLBL has no P/E (earnings not positive) and is left out · hover or tap a dot for values.
Climb Global Solutions, Inc. — questions
- What is Climb Global Solutions, Inc.'s market cap?
- $612.8M.
- What is Climb Global Solutions, Inc.'s P/E ratio?
- 29.7 on trailing twelve-month earnings to 2026-06-30.
- What is Climb Global Solutions, Inc.'s price-to-sales ratio?
- 0.9.
Every figure on this page comes from Climb Global Solutions, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.